drugset / Trial / NCT01418274
A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This single-arm, open-label, non-randomized study will evaluate the effect of danoprevir/ritonavir on the pharmacokinetics of escitalopram and S-demethylcitalopram in healthy volunteers. Healthy volunteers will receive oral doses of danoprevir/ritonavir and escitalopram. The anticipated time of the study is 6 weeks.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | — | Oral |
| Subject | Ritonavir | Other / unclassified | — | Oral |
| Subject | danoprevir | Small molecule | — | Oral |
Indications
No indication recorded.